BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36456128)

  • 1. A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma.
    Motoyama S; Hosaka M; Kamei T; Ueno M; Watanabe M; Ohkura YU; Mine S; Tanabe S; Toyokawa T; Wakita A; Nishikawa K; Ninomiya I; Fujita K; Kanda M; Hirai M; Hoshi M; Chiu SW; Takata M; Yamaguchi T; Miura M
    Anticancer Res; 2022 Dec; 42(12):6105-6112. PubMed ID: 36456128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.
    Motoyama S; Mori K; Kamei T; Miura M; Hinai Y; Sato Y; Yoshino K; Sasaki T; Miyata G; Seto Y; Ogawa J
    Ann Surg Oncol; 2013 Jun; 20(6):1978-84. PubMed ID: 23212764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa.
    Oguma J; Ishiyama K; Kurita D; Kanematsu K; Kubo K; Utsunomiya D; Abe S; Makiguchi M; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Saito Y; Daiko H
    Surgery; 2023 May; 173(5):1162-1168. PubMed ID: 36801078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
    Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
    Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
    Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
    Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative Management After Endoscopic Resection for Esophageal Squamous Cell Carcinoma Invading Muscularis Mucosa or Shallow Submucosal Layer-Multicenter Real-World Survey in Japan.
    Katada C; Yokoyama T; Hirasawa D; Iizuka T; Kikuchi D; Yano T; Hombu T; Yoshio T; Yoshimizu S; Ono H; Yabuuchi Y; Terai S; Hashimoto S; Takahashi K; Tanaka S; Urabe Y; Arima M; Tanabe S; Wada T; Furue Y; Oyama T; Takahashi A; Sakamoto Y; Muto M
    Am J Gastroenterol; 2023 Jul; 118(7):1175-1183. PubMed ID: 36624037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRP 1846C>T Genetic Polymorphism Is Associated with Lymph Node Metastasis and/or Severe Lymphatic Invasion in Endometrial Cancer.
    Kito M; Motoyama S; Fujita K; Miura M; Nanjo H; Sato N; Shimizu D; Sato T; Makino K; Sugawara T; Kato A; Tamura D; Takahashi K; Kumazawa Y; Sato W; Miura H; Shirasawa H; Sato A; Kumagai J; Terada Y
    Tohoku J Exp Med; 2015 Sep; 237(1):25-30. PubMed ID: 26310275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
    Lu H; Bei Y; Wang C; Deng X; Hu Q; Guo W; Zhang X
    PLoS One; 2024; 19(2):e0298792. PubMed ID: 38386660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
    Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
    Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.
    Akutsu Y; Uesato M; Shuto K; Kono T; Hoshino I; Horibe D; Sazuka T; Takeshita N; Maruyama T; Isozaki Y; Akanuma N; Matsubara H
    Ann Surg; 2013 Jun; 257(6):1032-8. PubMed ID: 23108117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma.
    Qie P; Yin Q; Xun X; Song Y; Zhou S; Liu H; Feng J; Tian Z
    J Cardiothorac Surg; 2021 Mar; 16(1):48. PubMed ID: 33757566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential for lymph node metastasis using CRP 1846C>T genetic polymorphism in invasive breast cancer.
    Terata K; Motoyama S; Kamata S; Hinai Y; Miura M; Sato Y; Yoshino K; Ito A; Imai K; Saito H; Minamiya Y
    Tumour Biol; 2014 Jun; 35(6):5931-5. PubMed ID: 24633920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma.
    Namikawa K; Yoshio T; Yoshimizu S; Ishiyama A; Tsuchida T; Tokai Y; Horiuchi Y; Hirasawa T; Fujisaki J
    Sci Rep; 2021 Mar; 11(1):6554. PubMed ID: 33753766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.
    Ikawa T; Ishihara R; Konishi K; Morimoto M; Hirata T; Kanayama N; Yamamoto S; Matsuura N; Wada K; Hayashi K; Ogawa K; Teshima T
    Cancer Med; 2019 Aug; 8(10):4547-4554. PubMed ID: 31222974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
    Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
    Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.